LOINC_NUM
stringlengths 3
8
| COMPONENT
stringlengths 2
246
| PROPERTY
stringlengths 1
29
| TIME_ASPCT
stringlengths 1
15
| SYSTEM
stringlengths 1
106
| SCALE_TYP
stringclasses 10
values | METHOD_TYP
stringlengths 1
57
⌀ | CLASS
stringlengths 2
24
| CLASSTYPE
int64 1
4
| LONG_COMMON_NAME
stringlengths 3
254
| SHORTNAME
stringlengths 2
51
⌀ | EXTERNAL_COPYRIGHT_NOTICE
stringlengths 39
2.6k
⌀ | STATUS
stringclasses 4
values | VersionFirstReleased
stringlengths 1
7
| VersionLastChanged
stringlengths 1
5
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
98166-2
|
What do you think is your current risk that, in case of infection or re-infection, you will experience severe complications or even death
|
Score
|
Pt
|
^Patient
|
Qn
| null |
SURVEY.COVID
| 4 |
What do you think is your current risk that, in case of infection or re-infection, you will experience severe complications or even death
| null | null |
ACTIVE
|
2.71
|
2.71
|
98167-0
|
How often do you wash your hands with hand-soap or hydro-alcoholic solutions
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.COVID
| 4 |
How often do you wash your hands with hand-soap or hydro-alcoholic solutions
| null | null |
ACTIVE
|
2.71
|
2.71
|
98168-8
|
How often do you keep a distance of at least 2 meters from others
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.COVID
| 4 |
How often do you keep a distance of at least 2 meters from others
| null | null |
ACTIVE
|
2.71
|
2.71
|
98169-6
|
Stay at home to avoid social contact
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.COVID
| 4 |
Stay at home to avoid social contact
| null | null |
ACTIVE
|
2.71
|
2.71
|
98170-4
|
Wear face mask in public
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.COVID
| 4 |
Wear face mask in public
| null | null |
ACTIVE
|
2.71
|
2.71
|
98171-2
|
Has been offered COVID-19 vaccine
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.COVID
| 4 |
Has been offered COVID-19 vaccine
| null | null |
ACTIVE
|
2.71
|
2.71
|
98172-0
|
Accepted or will accept COVID-19 vaccination once offered
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.COVID
| 4 |
Accepted or will accept COVID-19 vaccination once offered
| null | null |
ACTIVE
|
2.71
|
2.71
|
98173-8
|
Reasons for not accepting COVID-19 vaccine
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.COVID
| 4 |
Reasons for not accepting COVID-19 vaccine
| null | null |
ACTIVE
|
2.71
|
2.71
|
98174-6
|
Routine doctor's visits &or check-ups cancelled in the last 12Mo
|
Find
|
12Mo
|
^Patient
|
Ord
| null |
SURVEY.COVID
| 4 |
Routine doctor's visits AndOr check-ups cancelled in the last 12 months
| null | null |
ACTIVE
|
2.71
|
2.71
|
98175-3
|
Routine doctor's visits &or check-ups postponed in the last 12Mo
|
Find
|
12Mo
|
^Patient
|
Ord
| null |
SURVEY.COVID
| 4 |
Routine doctor's visits AndOr check-ups postponed in the last 12 months
| null | null |
ACTIVE
|
2.71
|
2.71
|
98176-1
|
Problems accessing medication in last 12Mo
|
Find
|
12Mo
|
^Patient
|
Ord
| null |
SURVEY.COVID
| 4 |
Problems accessing medication in last 12 months
| null | null |
ACTIVE
|
2.71
|
2.71
|
98177-9
|
Treatment sessions postponed by doctor or patient in the last 12Mo
|
Find
|
12Mo
|
^Patient
|
Ord
| null |
SURVEY.COVID
| 4 |
Treatment sessions postponed by doctor or patient in the last 12 months
| null | null |
ACTIVE
|
2.71
|
2.71
|
9817-8
|
Cryptococcus sp Ag
|
Titr
|
Pt
|
CSF
|
Qn
|
IA
|
MICRO
| 1 |
Cryptococcus sp Ag [Titer] in Cerebral spinal fluid by Immunoassay
|
Cryptoc Ag Titr CSF IA
| null |
ACTIVE
|
1.0i
|
2.73
|
98178-7
|
Treatment sessions cancelled by doctor or patient in the last 12Mo
|
Find
|
12Mo
|
^Patient
|
Ord
| null |
SURVEY.COVID
| 4 |
Treatment sessions cancelled by doctor or patient in the last 12 months
| null | null |
ACTIVE
|
2.71
|
2.71
|
98179-5
|
Financial problems in last 12 Mo
|
Find
|
12Mo
|
^Patient
|
Ord
| null |
SURVEY.COVID
| 4 |
Financial problems in last 12 months
| null | null |
ACTIVE
|
2.71
|
2.71
|
98180-3
|
Received any financial or material aid in last 12 Mo
|
Find
|
12Mo
|
^Patient
|
Ord
| null |
SURVEY.COVID
| 4 |
Received any financial or material aid in last 12 months
| null | null |
ACTIVE
|
2.71
|
2.71
|
98181-1
|
Medical equipment used
|
Type
|
Pt
|
^Patient
|
Nom
| null |
H&P.HX
| 2 |
Medical equipment used
|
Medical equipment used
| null |
ACTIVE
|
2.71
|
2.71
|
98182-9
|
Thyroxine.free
|
SCnc
|
Pt
|
BldCo
|
Qn
| null |
CHEM
| 1 |
Thyroxine (T4) free [Moles/volume] in Cord blood
|
T4 Free BldCo-sCnc
| null |
ACTIVE
|
2.71
|
2.71
|
98183-7
|
Wild boar dander Ab.IgE
|
ACnc
|
Pt
|
Ser
|
Qn
| null |
ALLERGY
| 1 |
Wild boar dander IgE Ab [Units/volume] in Serum
|
Wild boar dander IgE Qn
| null |
ACTIVE
|
2.71
|
2.71
|
98184-5
|
Acetylcysteine Ab.IgE
|
ACnc
|
Pt
|
Ser
|
Qn
| null |
ALLERGY
| 1 |
Acetylcysteine IgE Ab [Units/volume] in Serum
|
NAC IgE Qn
| null |
ACTIVE
|
2.71
|
2.71
|
98185-2
|
Ambroxol Ab.IgE
|
ACnc
|
Pt
|
Ser
|
Qn
| null |
ALLERGY
| 1 |
Ambroxol IgE Ab [Units/volume] in Serum
|
Ambroxol IgE Qn
| null |
ACTIVE
|
2.71
|
2.71
|
9818-6
|
Cryptococcus sp Ag
|
Titr
|
Pt
|
Ser
|
Qn
|
IA
|
MICRO
| 1 |
Cryptococcus sp Ag [Titer] in Serum by Immunoassay
|
Cryptoc Ag Titr Ser IA
| null |
ACTIVE
|
1.0i
|
2.73
|
98186-0
|
Aspartame Ab.IgE
|
ACnc
|
Pt
|
Ser
|
Qn
| null |
ALLERGY
| 1 |
Aspartame IgE Ab [Units/volume] in Serum
|
Aspartame IgE Qn
| null |
ACTIVE
|
2.71
|
2.71
|
98187-8
|
Aspergillus repens Ab.IgE
|
ACnc
|
Pt
|
Ser
|
Qn
| null |
ALLERGY
| 1 |
Aspergillus repens IgE Ab [Units/volume] in Serum
|
Aspergillus repens IgE Qn
| null |
ACTIVE
|
2.71
|
2.71
|
98188-6
|
Bacampicillin Ab.IgE
|
ACnc
|
Pt
|
Ser
|
Qn
| null |
ALLERGY
| 1 |
Bacampicillin IgE Ab [Units/volume] in Serum
|
Bacampicillin IgE Qn
| null |
ACTIVE
|
2.71
|
2.71
|
98189-4
|
Benzocaine Ab.IgE
|
ACnc
|
Pt
|
Ser
|
Qn
| null |
ALLERGY
| 1 |
Benzocaine IgE Ab [Units/volume] in Serum
|
Benzocaine IgE Qn
| null |
ACTIVE
|
2.71
|
2.71
|
98190-2
|
Bromhexine Ab.IgE
|
ACnc
|
Pt
|
Ser
|
Qn
| null |
ALLERGY
| 1 |
Bromhexine IgE Ab [Units/volume] in Serum
|
Bromhexine IgE Qn
| null |
ACTIVE
|
2.71
|
2.71
|
98191-0
|
Azlocillin Ab.IgE
|
ACnc
|
Pt
|
Ser
|
Qn
| null |
ALLERGY
| 1 |
Azlocillin IgE Ab [Units/volume] in Serum
|
Azlocillin IgE Qn
| null |
ACTIVE
|
2.71
|
2.71
|
98192-8
|
Cephalothin Ab.IgE
|
ACnc
|
Pt
|
Ser
|
Qn
| null |
ALLERGY
| 1 |
Cephalothin IgE Ab [Units/volume] in Serum
|
Cephalothin IgE Qn
| null |
ACTIVE
|
2.71
|
2.71
|
98193-6
|
Begonia semperflorens Ab.IgE
|
ACnc
|
Pt
|
Ser
|
Qn
| null |
ALLERGY
| 1 |
Wax begonia IgE Ab [Units/volume] in Serum
|
Wax begonia IgE Qn
| null |
ACTIVE
|
2.71
|
2.71
|
9819-4
|
Cryptococcus sp Ag
|
Titr
|
Pt
|
CSF
|
Qn
|
LA
|
MICRO
| 1 |
Cryptococcus sp Ag [Titer] in Cerebral spinal fluid by Latex agglutination
|
Cryptoc Ag Titr CSF LA
| null |
ACTIVE
|
1.0i
|
2.73
|
98194-4
|
Hibiscus tea Ab.IgE
|
ACnc
|
Pt
|
Ser
|
Qn
| null |
ALLERGY
| 1 |
Hibiscus tea IgE Ab [Units/volume] in Serum
|
Hibiscus tea IgE Qn
| null |
ACTIVE
|
2.71
|
2.71
|
98195-1
|
Diatrizoate Ab.IgE
|
ACnc
|
Pt
|
Ser
|
Qn
| null |
ALLERGY
| 1 |
Diatrizoate IgE Ab [Units/volume] in Serum
|
Diatrizoate IgE Qn
| null |
ACTIVE
|
2.71
|
2.71
|
98196-9
|
Echinacea Ab.IgE
|
ACnc
|
Pt
|
Ser
|
Qn
| null |
ALLERGY
| 1 |
Echinacea IgE Ab [Units/volume] in Serum
|
Echinacea IgE Qn
| null |
ACTIVE
|
2.71
|
2.71
|
98197-7
|
EPINEPHrine Ab.IgE
|
ACnc
|
Pt
|
Ser
|
Qn
| null |
ALLERGY
| 1 |
EPINEPHrine IgE Ab [Units/volume] in Serum
|
Epineph IgE Qn
| null |
ACTIVE
|
2.71
|
2.71
|
98198-5
|
Erythrosine B Ab.IgE
|
ACnc
|
Pt
|
Ser
|
Qn
| null |
ALLERGY
| 1 |
Erythrosine B IgE Ab [Units/volume] in Serum
|
Erythrosine B IgE Qn
| null |
ACTIVE
|
2.71
|
2.71
|
98199-3
|
Phenacetin Ab.IgE
|
ACnc
|
Pt
|
Ser
|
Qn
| null |
ALLERGY
| 1 |
Phenacetin IgE Ab [Units/volume] in Serum
|
Phenac IgE Qn
| null |
ACTIVE
|
2.71
|
2.71
|
98200-9
|
Paraphenylenediamine Ab.IgE
|
ACnc
|
Pt
|
Ser
|
Qn
| null |
ALLERGY
| 1 |
Paraphenylenediamine IgE Ab [Units/volume] in Serum
|
Paraphenylenediamine IgE Qn
| null |
ACTIVE
|
2.71
|
2.71
|
98201-7
|
Fuchsia spp Ab.IgE
|
ACnc
|
Pt
|
Ser
|
Qn
| null |
ALLERGY
| 1 |
Fuchsia spp IgE Ab [Units/volume] in Serum
|
Fuchsia spp IgE Qn
| null |
ACTIVE
|
2.71
|
2.71
|
9820-2
|
Cryptococcus sp Ag
|
Titr
|
Pt
|
Ser
|
Qn
|
LA
|
MICRO
| 1 |
Cryptococcus sp Ag [Titer] in Serum by Latex agglutination
|
Cryptoc Ag Titr Ser LA
| null |
ACTIVE
|
1.0i
|
2.73
|
98202-5
|
Ginkgo Ab.IgE
|
ACnc
|
Pt
|
Ser
|
Qn
| null |
ALLERGY
| 1 |
Ginkgo IgE Ab [Units/volume] in Serum
|
Ginkgo IgE Qn
| null |
ACTIVE
|
2.71
|
2.71
|
98203-3
|
(Diffusion capacity/Alveolar volume)/predicted
|
RelInvVI
|
Pt
|
Respiratory system
|
Qn
| null |
PULM
| 2 |
(Diffusion capacity/Alveolar volume)/predicted
|
(Diff cap/Alv vol)/predicted
| null |
ACTIVE
|
2.71
|
2.71
|
98204-1
|
Borrelia burgdorferi Ab.IgG & IgM bands panel
|
-
|
Pt
|
Ser
|
-
|
IB
|
PANEL.MICRO
| 1 |
Borrelia burgdorferi IgG and IgM bands panel - Serum by Immunoblot
|
B burgdor IgG+IgM bands Pnl Ser IB
| null |
ACTIVE
|
2.71
|
2.71
|
98205-8
|
Borrelia burgdorferi Ab.IgG & IgM & total panel
|
-
|
Pt
|
Ser
|
-
|
IA
|
PANEL.MICRO
| 1 |
Borrelia burgdorferi IgG and IgM and total panel - Serum by Immunoassay
|
B burgdor IgG + IgM + tot Pnl Ser IA
| null |
ACTIVE
|
2.71
|
2.71
|
98206-6
|
Borrelia burgdorferi 21kD Ab.IgG
|
PrThr
|
Pt
|
Ser
|
Ord
|
IB
|
MICRO
| 1 |
Borrelia burgdorferi 21kD IgG Ab [Presence] in Serum by Immunoblot
|
B burgdor21kD IgG Ser Ql IB
| null |
ACTIVE
|
2.71
|
2.71
|
98207-4
|
Borrelia burgdorferi Ab.IgG & IgM panel
|
-
|
Pt
|
CSF
|
-
|
IA
|
PANEL.MICRO
| 1 |
Borrelia burgdorferi IgG and IgM panel - Cerebral spinal fluid by Immunoassay
|
B burgdor IgG+IgM Pnl CSF IA
| null |
ACTIVE
|
2.71
|
2.71
|
98208-2
|
Borrelia burgdorferi Ab.IgM
|
PrThr
|
Pt
|
CSF
|
Ord
|
IA
|
MICRO
| 1 |
Borrelia burgdorferi IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
|
B burgdor IgM CSF Ql IA
| null |
ACTIVE
|
2.71
|
2.71
|
98209-0
|
Legionella pneumophila Ab.IgG & IgM panel
|
-
|
Pt
|
Ser
|
-
| null |
PANEL.MICRO
| 1 |
Legionella pneumophila IgG and IgM panel - Serum
|
L pneumophila IgG + IgM Pnl Ser
| null |
ACTIVE
|
2.71
|
2.71
|
9821-0
|
HIV 1 p24 Ag
|
PrThr
|
Pt
|
Ser
|
Ord
| null |
MICRO
| 1 |
HIV 1 p24 Ag [Presence] in Serum
|
HIV1 p24 Ag Ser Ql
| null |
ACTIVE
|
1.0i
|
2.73
|
98210-8
|
Legionella pneumophila Ab.IgM
|
PrThr
|
Pt
|
Ser
|
Ord
|
IA
|
MICRO
| 1 |
Legionella pneumophila IgM Ab [Presence] in Serum by Immunoassay
|
L pneumo IgM Ser Ql IA
| null |
ACTIVE
|
2.71
|
2.71
|
98211-6
|
Salmonella spp Ab panel
|
-
|
Pt
|
Ser
|
-
|
Aggl
|
PANEL.MICRO
| 1 |
Salmonella species antibody panel - Serum by Agglutination
|
Salmonella spp Ab Pnl Ser Aggl
| null |
ACTIVE
|
2.71
|
2.71
|
98212-4
|
Reagin Ab & Treponema pallidum Ab.IgG & IgM & total panel
|
-
|
Pt
|
Ser
|
-
| null |
PANEL.MICRO
| 1 |
Reagin Ab and Treponema pallidum IgG and IgM and total panel - Serum
|
Reag Ab + T pall IgG + IgM + tot Pnl Ser
| null |
ACTIVE
|
2.71
|
2.71
|
98213-2
|
Treponema pallidum Ab.IgG & IgM & bands panel
|
-
|
Pt
|
Ser
|
-
|
IB
|
PANEL.MICRO
| 1 |
Treponema pallidum IgG and IgM and bands panel - Serum by Immunoblot
|
T pall IgG + IgM + bands Pnl Ser IB
| null |
ACTIVE
|
2.71
|
2.71
|
98214-0
|
Reagin Ab & Treponema pallidum Ab.IgG & IgM & total panel
|
-
|
Pt
|
CSF
|
-
| null |
PANEL.MICRO
| 1 |
Reagin Ab and Treponema pallidum IgG and IgM and total panel - Cerebral spinal fluid
|
Reag Ab + T pall IgG + IgM + tot Pnl CSF
| null |
ACTIVE
|
2.71
|
2.71
|
98215-7
|
Treponema pallidum Ab
|
PrThr
|
Pt
|
CSF
|
Ord
|
IA
|
MICRO
| 1 |
Treponema pallidum Ab [Presence] in Cerebral spinal fluid by Immunoassay
|
T pallidum Ab CSF Ql IA
| null |
ACTIVE
|
2.71
|
2.71
|
98216-5
|
Treponema pallidum Ab
|
ACnc
|
Pt
|
CSF
|
Qn
|
IA
|
MICRO
| 1 |
Treponema pallidum Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
|
T pallidum Ab CSF IA-aCnc
| null |
ACTIVE
|
2.71
|
2.71
|
98217-3
|
Treponema pallidum Ab.IgG
|
Titr
|
Pt
|
CSF
|
Qn
|
IF
|
MICRO
| 1 |
Treponema pallidum IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
|
T pallidum IgG Titr CSF IF
| null |
ACTIVE
|
2.71
|
2.71
|
98218-1
|
Treponema pallidum Ab.IgM
|
Titr
|
Pt
|
CSF
|
Qn
|
IF
|
MICRO
| 1 |
Treponema pallidum IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
|
T pallidum IgM Titr CSF IF
| null |
ACTIVE
|
2.71
|
2.71
|
98219-9
|
Treponema pallidum Ab.IgG & IgM & bands panel
|
-
|
Pt
|
CSF
|
-
|
IB
|
PANEL.MICRO
| 1 |
Treponema pallidum IgG and IgM and bands panel - Cerebral spinal fluid by Immunoblot
|
T pall IgG + IgM + bands Pnl CSF IB
| null |
ACTIVE
|
2.71
|
2.71
|
98220-7
|
Treponema pallidum Ab.IgG
|
PrThr
|
Pt
|
CSF
|
Ord
|
IB
|
MICRO
| 1 |
Treponema pallidum IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot
|
T pallidum IgG CSF Ql IB
| null |
ACTIVE
|
2.71
|
2.71
|
98221-5
|
Treponema pallidum Ab.IgG bands
|
Prid
|
Pt
|
Ser
|
Nom
|
IB
|
MICRO
| 1 |
Treponema pallidum IgG bands [Identifier] in Serum by Immunoblot
|
T pallidum IgG bands Ser IB
| null |
ACTIVE
|
2.71
|
2.71
|
98222-3
|
Treponema pallidum Ab.IgG bands
|
Prid
|
Pt
|
CSF
|
Nom
|
IB
|
MICRO
| 1 |
Treponema pallidum IgG bands [Identifier] in Cerebral spinal fluid by Immunoblot
|
T pallidum IgG bands CSF IB
| null |
ACTIVE
|
2.71
|
2.71
|
98223-1
|
Treponema pallidum Ab.IgM bands
|
Prid
|
Pt
|
Ser
|
Nom
|
IB
|
MICRO
| 1 |
Treponema pallidum IgM bands [Identifier] in Serum by Immunoblot
|
T pallidum IgM bands Ser IB
| null |
ACTIVE
|
2.71
|
2.71
|
98224-9
|
Treponema pallidum Ab.IgM bands
|
Prid
|
Pt
|
CSF
|
Nom
|
IB
|
MICRO
| 1 |
Treponema pallidum IgM bands [Identifier] in Cerebral spinal fluid by Immunoblot
|
T pallidum IgM bands CSF IB
| null |
ACTIVE
|
2.71
|
2.71
|
98225-6
|
Piperacillin Ab.IgE
|
ACnc
|
Pt
|
Ser
|
Qn
| null |
ALLERGY
| 1 |
Piperacillin IgE Ab [Units/volume] in Serum
|
Piperacillin IgE Qn
| null |
ACTIVE
|
2.71
|
2.71
|
98226-4
|
Prednisolone Ab.IgE
|
ACnc
|
Pt
|
Ser
|
Qn
| null |
ALLERGY
| 1 |
prednisoLONE IgE Ab [Units/volume] in Serum
|
prednisoLONE IgE Qn
| null |
ACTIVE
|
2.71
|
2.71
|
98227-2
|
Prilocaine Ab.IgE
|
ACnc
|
Pt
|
Ser
|
Qn
| null |
ALLERGY
| 1 |
Prilocaine IgE Ab [Units/volume] in Serum
|
Prilocaine IgE Qn
| null |
ACTIVE
|
2.71
|
2.71
|
9822-8
|
Bacteria identified
|
Prid
|
Pt
|
Dial fld
|
Nom
|
Culture
|
MICRO
| 1 |
Bacteria identified in Dialysis fluid by Culture
|
Bacteria Dial fld Cult
| null |
ACTIVE
|
1.0i
|
2.73
|
98228-0
|
Procaine Ab.IgE
|
ACnc
|
Pt
|
Ser
|
Qn
| null |
ALLERGY
| 1 |
Deprecated Procaine IgE Ab [Units/volume] in Serum
|
Deprecated Procaine IgE Qn
| null |
DEPRECATED
|
2.71
|
2.72
|
98229-8
|
Ofloxacin Ab.IgE
|
ACnc
|
Pt
|
Ser
|
Qn
| null |
ALLERGY
| 1 |
Ofloxacin IgE Ab [Units/volume] in Serum
|
Ofloxacin IgE Qn
| null |
ACTIVE
|
2.71
|
2.71
|
98230-6
|
Zea mays starch Ab.IgE
|
ACnc
|
Pt
|
Ser
|
Qn
| null |
ALLERGY
| 1 |
Corn starch IgE Ab [Units/volume] in Serum
|
Corn starch IgE Qn
| null |
ACTIVE
|
2.71
|
2.71
|
98231-4
|
Sorbic acid Ab.IgE
|
ACnc
|
Pt
|
Ser
|
Qn
| null |
ALLERGY
| 1 |
Sorbic acid IgE Ab [Units/volume] in Serum
|
Sorbic acid IgE Qn
| null |
ACTIVE
|
2.71
|
2.71
|
98232-2
|
Hypericum perforatum Ab.IgE
|
ACnc
|
Pt
|
Ser
|
Qn
| null |
ALLERGY
| 1 |
St. John's wort IgE Ab [Units/volume] in Serum
|
St. John's wort IgE Qn
| null |
ACTIVE
|
2.71
|
2.71
|
98233-0
|
Physalis peruviana Ab.IgE
|
ACnc
|
Pt
|
Ser
|
Qn
| null |
ALLERGY
| 1 |
Cape gooseberry IgE Ab [Units/volume] in Serum
|
Cape gooseberry IgE Qn
| null |
ACTIVE
|
2.71
|
2.71
|
98234-8
|
Quail meat Ab.IgE
|
ACnc
|
Pt
|
Ser
|
Qn
| null |
ALLERGY
| 1 |
Quail meat IgE Ab [Units/volume] in Serum
|
Quail meat IgE Qn
| null |
ACTIVE
|
2.71
|
2.71
|
98235-5
|
Wild boar meat Ab.IgE
|
ACnc
|
Pt
|
Ser
|
Qn
| null |
ALLERGY
| 1 |
Wild boar meat IgE Ab [Units/volume] in Serum
|
Wild boar meat IgE Qn
| null |
ACTIVE
|
2.71
|
2.71
|
9823-6
|
Mycobacterium sp identified
|
Prid
|
Pt
|
Bronchial
|
Nom
|
Organism specific culture
|
MICRO
| 1 |
Mycobacterium sp identified in Bronchial specimen by Organism specific culture
|
Mycobacterium Bronch Cult
| null |
ACTIVE
|
1.0i
|
2.73
|
98236-3
|
Norfloxacin Ab.IgE
|
ACnc
|
Pt
|
Ser
|
Qn
| null |
ALLERGY
| 1 |
Norfloxacin IgE Ab [Units/volume] in Serum
|
Norfloxacin IgE Qn
| null |
ACTIVE
|
2.71
|
2.71
|
98237-1
|
Chemokine (C-X-C motif) ligand 1
|
MCnc
|
Pt
|
Ser/Plas
|
Qn
| null |
CHEM
| 1 |
Chemokine (C-X-C motif) ligand 1 [Mass/volume] in Serum or Plasma
|
CXCL1 SerPl-mCnc
| null |
ACTIVE
|
2.71
|
2.71
|
98238-9
|
Platelet-derived growth factor B+BB
|
MCnc
|
Pt
|
Ser/Plas
|
Qn
| null |
CHEM
| 1 |
Platelet-derived growth factor B+BB [Mass/volume] in Serum or Plasma
|
PDGF B+BB SerPl-mCnc
| null |
ACTIVE
|
2.71
|
2.71
|
98239-7
|
CD154 expression & function panel
|
-
|
Pt
|
T cells
|
-
|
Flow cytometry
|
PANEL.CELLMARK
| 1 |
CD154 expression and function panel - T cells by Flow cytometry (FC)
|
CD154 Expr+Func Pnl T cells FC
| null |
ACTIVE
|
2.71
|
2.71
|
98240-5
|
Cells.CD154
|
PrThr
|
Pt
|
T cells
|
Ord
| null |
CELLMARK
| 1 |
CD154 cells [Presence] in T cells
|
CD154 cells T cells Ql
| null |
ACTIVE
|
2.71
|
2.71
|
98241-3
|
CD154 function (binding to CD40)
|
PrThr
|
Pt
|
T cells
|
Ord
| null |
CELLMARK
| 1 |
CD154 function (binding to CD40) [Presence] in T cells
|
CD154 Function T cells Ql
| null |
ACTIVE
|
2.71
|
2.71
|
98242-1
|
Spermatozoa.motile^post ejaculation
|
NCnc
|
Pt
|
Urine
|
Qn
|
Microscopy.light
|
FERT
| 1 |
Spermatozoa Motile [#/volume] in Urine by Light microscopy --post ejaculation
|
Sperm Motile p ejac # Ur Micro
| null |
ACTIVE
|
2.71
|
2.71
|
98243-9
|
Spermatozoa^post ejaculation
|
NCnc
|
Pt
|
Urine
|
Qn
|
Microscopy.light
|
FERT
| 1 |
Spermatozoa [#/volume] in Urine by Light microscopy --post ejaculation
|
Sperm p ejac # Ur Micro
| null |
ACTIVE
|
2.71
|
2.71
|
9824-4
|
Mycobacterium sp identified
|
Prid
|
Pt
|
Gast fld
|
Nom
|
Organism specific culture
|
MICRO
| 1 |
Mycobacterium sp identified in Gastric fluid by Organism specific culture
|
Mycobacterium Gast Cult
| null |
ACTIVE
|
1.0i
|
2.19
|
98244-7
|
Spermatozoa.motile/100 spermatozoa^post ejaculation
|
NFr
|
Pt
|
Urine
|
Qn
|
Microscopy.light
|
FERT
| 1 |
Spermatozoa Motile/100 spermatozoa in Urine by Light microscopy --post ejaculation
|
Sperm Motile p ejac NFr Ur Micro
| null |
ACTIVE
|
2.71
|
2.71
|
98245-4
|
Spermatozoa motility^post ejaculation
|
Score
|
Pt
|
Urine
|
Ord
|
Microscopy.light
|
FERT
| 1 |
Spermatozoa motility [Score] in Urine Qualitative by Light microscopy --post ejaculation
|
Sperm motility p ejac Ur Ql Micro
| null |
ACTIVE
|
2.71
|
2.71
|
98246-2
|
Spermatozoa.motile^post ejaculation
|
Num
|
Pt
|
Urine
|
Qn
|
Microscopy.light
|
FERT
| 1 |
Spermatozoa Motile [#] in Urine by Light microscopy --post ejaculation
|
Sperm Motile p ejac Ur Micro
| null |
ACTIVE
|
2.71
|
2.71
|
98247-0
|
Spermatozoa.agglutinated^post ejaculation
|
PrThr
|
Pt
|
Urine
|
Ord
| null |
FERT
| 1 |
Spermatozoa Agglutinated [Presence] in Urine --post ejaculation
|
Sperm Agglutinated p ejac Ur Ql
| null |
ACTIVE
|
2.71
|
2.71
|
98248-8
|
Primary or recurrent or distant metastasis
|
Type
|
Pt
|
Tumor
|
Nom
| null |
PATH
| 1 |
Primary or recurrent or distant metastasis [Type] in Tumor
|
Primary, recurrent or dist metastasis
| null |
ACTIVE
|
2.71
|
2.71
|
98249-6
|
Cancer pathology panel
|
-
|
Pt
|
Endometrial cancer specimen
|
-
| null |
PANEL.PATH
| 1 |
Cancer pathology panel - Endometrial cancer specimen
|
Cancer Path Pnl EC spec
| null |
ACTIVE
|
2.71
|
2.71
|
98250-4
|
Neuroendocrine tumor
|
Type
|
Pt
|
Tumor
|
Nom
| null |
PATH
| 1 |
Neuroendocrine tumor [Type] in Tumor
|
Neuroendocrine tumor
| null |
ACTIVE
|
2.71
|
2.71
|
9825-1
|
Mycobacterium sp identified
|
Prid
|
Pt
|
Isolate
|
Nom
| null |
MICRO
| 1 |
Mycobacterium sp identified in Isolate
|
Mycobacterium Islt
| null |
ACTIVE
|
1.0i
|
2.73
|
98251-2
|
Stage
|
Type
|
Pt
|
Endometrial cancer specimen
|
Nom
|
FIGO
|
PATH
| 1 |
Stage [Type] in Endometrial cancer specimen by FIGO
|
Stage EC spec FIGO
| null |
ACTIVE
|
2.71
|
2.71
|
98252-0
|
Histologic grade
|
Find
|
Pt
|
Endometrial cancer specimen
|
Ord
| null |
PATH
| 1 |
Histologic grade in Endometrial cancer specimen Qualitative
|
Histo grade EC spec Ql
| null |
ACTIVE
|
2.71
|
2.71
|
98253-8
|
Myometrial invasion
|
PrThr
|
Pt
|
Endometrial cancer specimen
|
Ord
| null |
PATH
| 1 |
Myometrial invasion [Presence] in Endometrial cancer specimen
|
Myometrial invasion EC spec Ql
| null |
ACTIVE
|
2.71
|
2.71
|
98254-6
|
Depth of myometrial invasion
|
Len
|
Pt
|
Endometrial cancer specimen
|
Qn
| null |
PATH
| 1 |
Depth of myometrial invasion [Length] in Endometrial cancer specimen
|
Depth myometrial invasion EC spec
| null |
ACTIVE
|
2.71
|
2.71
|
98255-3
|
Depth of myometrial invasion/Myometrial thickness
|
LenFr
|
Pt
|
Endometrial cancer specimen
|
Qn
| null |
PATH
| 1 |
Depth of myometrial invasion/Myometrial thickness [Length fraction] in Endometrial cancer specimen
|
Myometrial invasion/Myometrial LenFr
| null |
ACTIVE
|
2.71
|
2.71
|
98256-1
|
Extent of myometrial invasion
|
Find
|
Pt
|
Endometrial cancer specimen
|
Ord
| null |
PATH
| 1 |
Extent of myometrial invasion in Endometrial cancer specimen Qualitative
|
Extent myometrial invasion EC spec Ql
| null |
ACTIVE
|
2.71
|
2.71
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.